Loading
Latest filing published 18 Sept 2026 for Knight Therapeutics Inc., €652. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
German Lopez appears in our data through filings on Knight Therapeutics Inc. shares, published by SEDI. In total, 4 filings cover trades dated from 15 June 2026 to 15 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 18 September 2026 with a share grant (€652) in Knight Therapeutics Inc. Filings reach the SEDI feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations